Merck lifts full-year forecast as Keytruda sales soar
Go back to Merck lifts full-year forecast as Keytruda sales soar| Merck & Co. (NYSE: MRK) | Delayed: 129.13 +0.47 (0.37%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $128.66 | 52 Week High | $65.46 | |||
| Open | $127.65 | 52 Week Low | $47.97 | |||
| Day High | $129.24 | P/E | 87.84 | |||
| Day Low | $126.74 | EPS | $1.47 | |||
| Volume | 4,027,346 | |||||

